hypercoagulable states md pathology exam question give Robbins based answer

Reading File
Finding Sources
Finding Sources
Searching PubMed

hypercoagulable states AND thrombophilia

Searching the Web

Robbins Pathologic Basis of Disease hypercoagulable states thrombosis inherited acquired thrombophilia

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File

Hypercoagulable States (Thrombophilia)

Definition: Hypercoagulability is an abnormally increased tendency of blood to clot, usually due to abnormalities of coagulation factors. It is an important contributor to venous thrombosis, though it may occasionally cause arterial or intracardiac thrombosis. It is the third component of Virchow triad, along with endothelial injury and abnormal blood flow.
Hypercoagulable states are classified into:
  1. Primary (inherited/genetic)
  2. Secondary (acquired)
Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 127

1. Primary (Inherited) Hypercoagulable States

A. Factor V Leiden mutation

  • Most common inherited thrombophilia.
  • Caused by a point mutation in factor V, producing Arg506Gln substitution.
  • Mutant factor V becomes resistant to cleavage and inactivation by activated protein C.
  • Consequently, the normal protein C anticoagulant pathway is impaired, favoring thrombosis.
  • Inherited in an autosomal dominant manner.
  • It mainly predisposes to venous thrombosis, especially DVT.
  • Heterozygotes have about a 4-8-fold increased relative risk of venous thrombosis; homozygotes have a higher risk.
  • Its effect is often apparent only when another risk factor, such as surgery, immobilization, pregnancy, or oral contraceptive use, is also present.

B. Prothrombin gene mutation

  • Usually the G20210A mutation in the 3′ untranslated region of the prothrombin gene.
  • Leads to increased prothrombin synthesis and hence increased circulating prothrombin levels.
  • Increases risk of venous thrombosis.
  • Heterozygotes have a roughly 2-4-fold increased risk; the risk is greater in homozygotes.

C. Deficiency of natural anticoagulants

These are relatively uncommon but important inherited causes:
DefectNormal function lostResult
Antithrombin III deficiencyInhibits thrombin and factors IXa, Xa, XIa, XIIaIncreased thrombin and factor Xa activity
Protein C deficiencyActivated protein C inactivates factors Va and VIIIaPersistence of factors Va and VIIIa
Protein S deficiencyCofactor for activated protein CReduced protein C action
  • These disorders commonly present with recurrent venous thrombosis or thromboembolism, often in adolescence or early adulthood.

D. Other inherited causes

  • Increased levels of factor VIII, IX, XI, or fibrinogen
  • Defects in fibrinolysis
  • Homocystinuria due to cystathionine beta-synthase deficiency
  • Hyperhomocysteinemia can promote thrombosis through endothelial injury and other prothrombotic effects.

2. Secondary (Acquired) Hypercoagulable States

Acquired thrombophilia is often multifactorial. It may act through increased procoagulants, reduced anticoagulant activity, platelet activation, endothelial injury, or stasis.

Important acquired causes

A. Prolonged immobilization

  • Bed rest, long-distance travel, paralysis, postoperative state.
  • Produces venous stasis and promotes DVT.

B. Tissue injury

  • Major surgery, fractures, burns, and trauma.
  • Tissue factor release, endothelial injury, inflammation, and immobilization all contribute.

C. Malignancy

  • Especially disseminated mucin-producing adenocarcinomas.
  • Tumors can release procoagulant substances, including tissue factor-like molecules.
  • May produce migratory thrombophlebitis, classically called Trousseau syndrome.

D. Pregnancy, postpartum state, and oral contraceptives

  • Hyperestrogenic states increase hepatic synthesis of clotting factors and reduce anticoagulant activity.
  • Pregnancy additionally causes venous stasis due to compression of pelvic veins.

E. Antiphospholipid antibody syndrome (APS)

An autoimmune thrombophilic disorder characterized by:
  • Antiphospholipid antibodies, including lupus anticoagulant, anticardiolipin antibodies, and anti-beta-2 glycoprotein I antibodies.
  • Venous or arterial thrombosis
  • Pregnancy morbidity: recurrent miscarriages, fetal death, or premature birth.
APS may be:
  • Primary, without another autoimmune disease
  • Secondary, most commonly associated with SLE
Paradox: Lupus anticoagulant may prolong phospholipid-dependent coagulation tests in vitro, but patients are thrombosis-prone in vivo.

F. Heparin-induced thrombocytopenia (HIT)

  • A serious prothrombotic complication of unfractionated heparin.
  • IgG antibodies form against heparin-PF4 complexes.
  • Immune complexes activate platelets through Fc receptors.
  • This causes:
    • Thrombocytopenia due to platelet removal
    • Marked platelet activation and thrombosis
  • Thrombosis can be venous or arterial and can lead to limb gangrene, skin necrosis, stroke, or myocardial infarction.

G. Other acquired conditions

  • Myocardial infarction
  • Atrial fibrillation
  • Prosthetic heart valves
  • Cardiomyopathy
  • Nephrotic syndrome
  • Disseminated intravascular coagulation
  • Sickle cell disease
  • Smoking
  • Obesity
  • Advanced age

Key pathogenetic concepts

  1. Inherited thrombophilias alone often cause only a moderate rise in risk.
  2. Thrombosis commonly follows a multiple-hit model: inherited susceptibility plus an acquired trigger such as immobilization, pregnancy, estrogen therapy, or surgery.
  3. Therefore, thrombophilia should be suspected in:
    • Recurrent thrombosis
    • Thrombosis at a young age, particularly before 50 years
    • Thrombosis at unusual sites
    • Strong family history of venous thromboembolism
    • Thrombosis occurring with relatively minor provoking factors

Short exam conclusion

Hypercoagulable states are inherited or acquired conditions that increase the risk of thrombosis, predominantly venous thrombosis. The common inherited disorders are factor V Leiden mutation and prothrombin G20210A mutation; deficiencies of antithrombin III, protein C, and protein S are less common. Major acquired causes include immobilization, trauma, malignancy, pregnancy, oral contraceptives, APS, and HIT. Thrombosis usually results from interaction between inherited predisposition and acquired environmental triggers.
Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 127.
This is a shared conversation. Sign in to Orris to start your own chat.